Armistice Capital, LLC Addex Therapeutics Ltd. Transaction History

Armistice Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.34 - $0.62 $92,820 - $169,260	273,000 Added 103.41%	537,000 $204,000
Q2 2023 Aug 14, 2023	BUY	$0.52 - $0.99 $137,280 - $261,360	264,000 New	264,000 $137,000
Q3 2022 Nov 14, 2022	BUY	$0.78 - $16.4 $52,246 - $1.1 Million	66,983 Added 26.47%	320,000 $256,000
Q2 2022 Aug 15, 2022	SELL	$1.05 - $5.35 $330,824 - $1.69 Million	-315,071 Reduced 55.46%	253,017 $291,000
Q1 2022 May 16, 2022	SELL	$4.27 - $6.83 $201,321 - $322,020	-47,148 Reduced 7.66%	568,088 $2.89 Million
Q4 2021 Feb 14, 2022	BUY	$6.29 - $9.4 $3.87 Million - $5.78 Million	615,236 New	615,236 $3.87 Million

Ticker ADXN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,204,630
Market Cap $64.8M
Description
Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs includ...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.